Ralf Lorenz
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in
- Co-authors
- Wolfgang Janni (16 shared papers)Andreas Schneeweiß (17 shared papers)Brigitte Rack (16 shared papers)Peter A. Fasching (15 shared papers)W. Lichtenegger (11 shared papers)Tanja Fehm (11 shared papers)Klaus Pantel (9 shared papers)Thomas W. P. Friedl (12 shared papers)
- Journals
- Cancer Research (7 papers)Journal of Clinical Oncology (6 papers)Transplantation (3 papers)Transplant International (2 papers)BMC Cancer (2 papers)
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Ralf Lorenz
43 papers receiving 1.1k citations
Ralf Lorenz's Hit Papers
Peers
Comparison fields: 5 of 80
- Cancer Research 515
- Oncology 638
- Reproductive Medicine 72
- Pathology and Forensic Medicine 126
- Surgery 306
Countries citing papers authored by Ralf Lorenz
This map shows the geographic impact of Ralf Lorenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Lorenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Lorenz more than expected).
Fields of papers citing papers by Ralf Lorenz
This network shows the impact of papers produced by Ralf Lorenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Lorenz. The network helps show where Ralf Lorenz may publish in the future.
Co-authors
The 25 scholars most cited alongside Ralf Lorenz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients Hit paper breakdown → | 2014 | 472 |
| 2 | 1996 | 91 | |
| 3 | 2010 | 76 | |
| 4 | 2018 | 55 | |
| 5 | 2001 | 55 | |
| 6 | 2010 | 34 | |
| 7 | 2001 | 33 | |
| 8 | 2018 | 32 | |
| 9 | 2002 | 28 | |
| 10 | 2004 | 25 | |
| 11 | 2000 | 25 | |
| 12 | 2005 | 20 | |
| 13 | 2018 | 19 | |
| 14 | Prevalence of CA 27.29 in primary breast cancer patients before the start of systemic treatment. | 2010 | 17 |
| 15 | 2016 | 14 | |
| 16 | 2022 | 13 | |
| 17 | 2016 | 12 | |
| 18 | 2020 | 12 | |
| 19 | 2016 | 11 | |
| 20 | 2018 | 9 |
About Ralf Lorenz
Ralf Lorenz is a scholar working on Oncology, Surgery, Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 44 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (10 papers), Xenotransplantation and immune response (10 papers), Breast Cancer Treatment Studies (9 papers), Advanced Breast Cancer Therapies (8 papers), HER2/EGFR in Cancer Research (7 papers), Organ Transplantation Techniques and Outcomes (6 papers), Tissue Engineering and Regenerative Medicine (4 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Cancer Research (515 citations), Oncology (638 citations), Reproductive Medicine (72 citations), Pathology and Forensic Medicine (126 citations) and Surgery (306 citations). Ralf Lorenz has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Wolfgang Janni, Andreas Schneeweiß, Brigitte Rack, Peter A. Fasching, W. Lichtenegger, Tanja Fehm, Klaus Pantel, Thomas W. P. Friedl, Hans Tesch and Matthias W. Beckmann. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Transplantation, Transplant International and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.